首页> 外文会议>World congress of the International Photodynamic Association >Antimicrobial Photodynamic Therapy for the Decolonization of Methicillin-Resistant Staphylococcus aureus from the Anterior Nares
【24h】

Antimicrobial Photodynamic Therapy for the Decolonization of Methicillin-Resistant Staphylococcus aureus from the Anterior Nares

机译:抗菌光动力学疗法从前鼻腔中分离耐甲氧西林金黄色葡萄球菌

获取原文

摘要

The nosocomial infection rate has increased dramatically due to emergence of antibiotic resistant bacterial strains such as methicillin resistant Staphylococcus aureus (MRSA). The primary anatomical site of MRSA colonization is the anterior nares, and this reservoir represents a primary vector of transmission from non-infected carriers to susceptible individuals. Antimicrobial photodynamic therapy (aPDT) has been used successfully for topical disinfection in the oral cavity. The aim of this study was to evaluate the utility of aPDT for nasal MRSA decolonization at the preclinical and clinical level. The nasal aPDT system consists of a 670 nm diode laser fibre-optically coupled to a disposable light diffusing tip, used to activate a methylene blue based photosensitizer formulation. Preclinical testing was done both in a custom nasal reservoir model and on human skin cultures colonized on the epithelial surface with MRSA. Human clinical testing was performed by clinicians in regions in which the system is approved by the regulatory authority. In vitro testing demonstrated that aPDT eradicated planktonic MRSA in an energy and photosensitizer concentration dependent manner. Furthermore, aPDT eliminated sustained colonization of MRSA on cultured human epithelial surfaces, an effect that was sustained over multiple days post-treatment. In preliminary human testing, aPDT eradicated MRSA completely from the nose with total treatment times < 10 minutes. aPDT is effective against MRSA when used topically in the nose. Energy dose and photosensitizer parameters have been optimized for the nasal environment. Controlled clinical studies are currently underway to further evaluate safety and efficacy.
机译:由于出现了耐抗生素的细菌菌株,例如耐甲氧西林的金黄色葡萄球菌(MRSA),导致医院内感染率急剧上升。 MRSA定植的主要解剖部位是前鼻孔,并且该贮藏库是从未感染的载体向易感个体传播的主要载体。抗菌光动力疗法(aPDT)已成功用于口腔局部消毒。这项研究的目的是在临床前和临床水平上评估aPDT在鼻MRSA非殖民化中的效用。鼻aPDT系统由一个670 nm的二极管激光器组成,该激光器光纤耦合到一次性光扩散尖端,用于激活基于亚甲基蓝的光敏剂配方。临床前测试是在定制的鼻腔贮藏模型中以及在用MRSA定植在上皮表面的人类皮肤培养物中进行的。人体临床测试是由监管机构批准该系统的地区的临床医生进行的。体外测试表明,aPDT以能量和光敏剂浓度依赖性方式消除了浮游性MRSA。此外,aPDT消除了在培养的人上皮表面上MRSA的持续定植,这种作用在治疗后持续了多天。在初步的人体测试中,aPDT完全从鼻子根除了MRSA,总治疗时间少于10分钟。当在鼻子上局部使用时,aPDT对MRSA有效。能量剂量和光敏剂参数已针对鼻腔环境进行了优化。目前正在进行对照临床研究,以进一步评估安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号